Raymond James Financial’s PolyPid PYPD Stock Holding History

Raymond James Financial’s Portfolio PYPD Stock Details PYPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-65	Closed	-$229	–	6322
2025 Q2	$229	Buy	+65	New	+$190	﹤0.01%	6767

Other funds holding PYPD

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return

Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Raymond James Financial's PYPD Position: Q3 2025 in Review

Raymond James Financial sold out of PolyPid (PYPD) in Q3 2025, closing a stake of 65 shares — an estimated $229 sold.

Raymond James Financial first reported a position in PYPD in Q2 2025 and held it in 1 quarter. The position peaked at $229 in Q2 2025. 16 funds tracked by Wall St. Rank hold PYPD as of Q3 2025.

Raymond James Financial reported no remaining PolyPid position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 65 PolyPid shares in Q3 2025, an estimated $229.
Raymond James Financial first reported a position in PolyPid in Q2 2025 and held it in 1 quarter.
Raymond James Financial's PolyPid position peaked at $229 in Q2 2025.
16 funds tracked by Wall St. Rank held PolyPid as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.